TRAF2 and hepatocellular carcinoma: In liver cancer, low expression of TRAF2 was associated with an unfavorable prognosis, and loss of TRAF2 can induce caspase-8 hyperactivation and impaired NF-κB activation, promoting the tumorigenesis and progression of hepatocellular carcinoma [15].